Literature DB >> 1689911

The effect of FK 506 and CyA on the Lewis rat renal ischemia model.

M A Nalesnik1, H S Lai, N Murase, S Todo, T E Starzl.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1689911      PMCID: PMC3003920     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  12 in total

1.  Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine.

Authors:  N Murase; S Todo; P H Lee; H S Lai; F Chapman; M A Nalesnik; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

2.  Effect of FK506 in experimental organ transplantation.

Authors:  S Todo; N Murase; Y Ueda; L Podesta; P ChapChap; D Kahn; K Okuda; O Imventarza; A Casavilla; J Demetris
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

3.  Studies on FK506 in experimental organ transplantation.

Authors:  T Ochiai; K Sakamoto; M Nagata; K Nakajima; T Goto; S Hori; T Kenmochi; T Nakagori; T Asano; K Isono
Journal:  Transplant Proc       Date:  1988-02       Impact factor: 1.066

4.  Renal transplantation in baboons under FK 506.

Authors:  S Todo; A Demetris; Y Ueda; O Imventarza; E Cadoff; A Zeevi; T E Starzl
Journal:  Surgery       Date:  1989-08       Impact factor: 3.982

5.  Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A.

Authors:  A Zeevi; R Duquesnoy; G Eiras; H Rabinowich; S Todo; L Makowka; T E Starzl
Journal:  Transplant Proc       Date:  1987-10       Impact factor: 1.066

6.  Cyclosporine--relationship of side effects to mode of action.

Authors:  B Ryffel; B M Foxwell; A Gee; B Greiner; G Woerly; M J Mihatsch
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

7.  IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION.

Authors:  A Zeevi; R Duquesnoy; G Eiras; S Todo; L Makowka; T Starzl
Journal:  Surg Res Commun       Date:  1987

8.  Cyclosporin A hepatotoxicity in 66 renal allograft recipients.

Authors:  G B Klintmalm; S Iwatsuki; T E Starzl
Journal:  Transplantation       Date:  1981-12       Impact factor: 4.939

9.  Effect of cyclosporine on interleukin 2 receptor expression in a human alloreactive T cell clone.

Authors:  D Chabannes; B Le Mauff; M M Hallet; Y Yacques; J P Soulillou
Journal:  Transplantation       Date:  1988-08       Impact factor: 4.939

10.  Kidney pathology in liver allograft recipients after long-term treatment with cyclosporin A.

Authors:  F E Dische; J Neuberger; J Keating; V Parsons; R Y Calne; R Williams
Journal:  Lab Invest       Date:  1988-04       Impact factor: 5.662

View more
  9 in total

1.  In vitro effects of cyclosporine and FK 506 on the renal cortex.

Authors:  S J Prasad; J McCauley; G Salama; T E Starzl; S A Murray
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

2.  Pharmacokinetics of cyclosporine and nephrotoxicity in orthotopic liver transplant patients rescued with FK 506.

Authors:  A B Jain; R Venkataramanan; J Fung; G Burckart; J Emeigh; W Diven; V Warty; K Abu-Elmagd; S Todo; M Alessiani
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

3.  Interaction between FK 506 and cyclosporine in dogs.

Authors:  Y M Wu; R Venkataramanan; M Suzuki; Y Zhu; H Abdallah; J Emeigh; G J Burckart; V S Warty; J J Fung; S Todo
Journal:  Transplant Proc       Date:  1991-12       Impact factor: 1.066

4.  Use of prostaglandin E1 in crossmatch-negative liver transplant recipients treated with FK 506.

Authors:  S Takaya; O Bronsther; K Abu-Elmagd; H Ramos; J J Fung; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1993-06       Impact factor: 1.066

5.  The histopathological changes associated with allograft rejection and drug toxicity in renal transplant recipients maintained on FK506. Clinical significance and comparison with cyclosporine.

Authors:  P S Randhawa; R Shapiro; M L Jordan; T E Starzl; A J Demetris
Journal:  Am J Surg Pathol       Date:  1993-01       Impact factor: 6.394

6.  Tacrolimus (FK506)-Associated Renal Pathology.

Authors:  Parmjeet S Randhawa; Thomas E Starzl; Anthony Jake Demetris
Journal:  Adv Anat Pathol       Date:  1997-07       Impact factor: 3.875

7.  Kidney transplantation under FK 506.

Authors:  T E Starzl; J Fung; M Jordan; R Shapiro; A Tzakis; J McCauley; J Johnston; Y Iwaki; A Jain; M Alessiani
Journal:  JAMA       Date:  1990-07-04       Impact factor: 56.272

8.  The question of FK 506 nephrotoxicity after liver transplantation.

Authors:  J McCauley; S Takaya; J Fung; A Tzakis; K Abu-Elmagd; A Jain; S Todo; T E Starzl
Journal:  Transplant Proc       Date:  1991-02       Impact factor: 1.066

9.  The protective effect of FK506 pretreatment against renal ischemia/reperfusion injury in rats.

Authors:  M Sakr; G Zetti; C McClain; J Gavaler; M Nalesnik; S Todo; T Starzl; D Van Thiel
Journal:  Transplantation       Date:  1992-05       Impact factor: 4.939

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.